Resolutions at the Extraordinary General Meeting in BioInvent on November 27, 2020 PR Newswire LUND, Sweden, Nov. 27, 2020 LUND, Sweden, Nov. 27...
BioInvent Interim Report January 1 - September 30, 2020 PR Newswire LUND, Sweden, Oct. 29, 2020 LUND, Sweden, Oct. 29, 2020 /PRNewswire/...
BioInvent Interim Report January 1 - June 30, 2020 PR Newswire LUND, Sweden, Aug. 27, 2020 Successful financing underpins exciting pipeline...
BioInvent Interim Report January 1 - June 30, 2020 Successful financing underpins exciting pipeline progress PR Newswire LUND, Sweden, Aug. 27...
Proposal for a New Board Member to be Elected at the Extraordinary General Meeting on July 3, 2020 PR Newswire Lund, Sweden, June 18, 2020 Lund...
BioInvent Interim Report January 1 - March 31, 2020 PR Newswire LUND, Sweden, April 28, 2020 LUND, Sweden, April 28, 2020 /PRNewswire/...
BioInvent Financial Statement January 1 - December 31, 2019 PR Newswire LUND, Sweden, Feb. 27, 2020 - Delivering on our goals and anticipating...
BioInvent Financial Statement January 1 - December 31, 2019 Delivering on our goals and anticipating important milestones in 2020 PR...
BioInvent: Interim Report January 1 - June 30, 2019 PR Newswire LUND, Sweden, Aug. 22, 2019 LUND, Sweden, Aug. 22, 2019 /PRNewswire/ -- "We are...
BioInvent's Partner Oxurion NV has Reported Topline Month 3 Results of Phase lla Study Evaluating THR-317 (anti-PLGF), in Combination With...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.